Alaunos Therapeutics raises ~$2.05M in registered direct offering of stock and pre-funded warrants

Alaunos Therapeutics, Inc.

338,725 shares at $3.36; 271,674 pre-funded warrants at $3.359/share.
Total gross proceeds ~$2.05M; offering closed June 24, 2025.
Net proceeds for general corporate purposes, including working capital and capex.
Offered under effective shelf registration statement (File No. 333-266841).
Pre-funded warrants have $0.001 exercise price; 4.99% or 9.99% beneficial ownership limit.

item 1.01item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.